Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 27, 2021

SELL
$4.17 - $5.74 $106,118 - $146,071
-25,448 Closed
0 $0
Q1 2021

May 03, 2021

SELL
$5.28 - $9.64 $10,575 - $19,308
-2,003 Reduced 7.3%
25,448 $134,000
Q4 2020

Feb 04, 2021

SELL
$5.75 - $7.13 $25,777 - $31,963
-4,483 Reduced 14.04%
27,451 $179,000
Q3 2020

Nov 06, 2020

BUY
$4.9 - $7.12 $26,817 - $38,967
5,473 Added 20.68%
31,934 $195,000
Q2 2020

Aug 04, 2020

SELL
$6.43 - $9.86 $12,744 - $19,542
-1,982 Reduced 6.97%
26,461 $192,000
Q1 2020

Apr 27, 2020

BUY
$6.36 - $10.05 $35,259 - $55,717
5,544 Added 24.21%
28,443 $198,000
Q4 2019

Feb 03, 2020

BUY
$8.49 - $12.81 $611 - $922
72 Added 0.32%
22,899 $202,000
Q3 2019

Oct 31, 2019

SELL
$5.58 - $14.47 $2,187 - $5,672
-392 Reduced 1.69%
22,827 $256,000
Q2 2019

Aug 09, 2019

BUY
$5.22 - $9.08 $62 - $108
12 Added 0.05%
23,219 $141,000
Q1 2019

May 02, 2019

BUY
$5.35 - $9.82 $5,510 - $10,114
1,030 Added 4.64%
23,207 $183,000
Q4 2018

Feb 11, 2019

BUY
$3.43 - $6.19 $3,025 - $5,459
882 Added 4.14%
22,177 $110,000
Q3 2018

Oct 22, 2018

BUY
$4.75 - $14.5 $7,923 - $24,186
1,668 Added 8.5%
21,295 $101,000
Q2 2018

Jul 23, 2018

SELL
$13.3 - $17.45 $5,519 - $7,241
-415 Reduced 2.07%
19,627 $267,000
Q1 2018

Apr 20, 2018

SELL
$14.7 - $24.95 $4,821 - $8,183
-328 Reduced 1.61%
20,042 $322,000
Q4 2017

Jan 23, 2018

SELL
$19.9 - $29.25 $27,959 - $41,096
-1,405 Reduced 6.45%
20,370 $473,000
Q3 2017

Nov 13, 2017

BUY
$15.1 - $19.25 $328,802 - $419,168
21,775
21,775 $402,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.